BSLK
Bolt Projects Holdings, Inc.1.8100
-0.0130-0.71%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
No earnings call transcript available
Key Stats
Market Cap
7.90MP/E (TTM)
0.06Basic EPS (TTM)
29.82Dividend Yield
0%Recent Filings
8-K
Auditor resigns amid weaknesses
Bolt Projects Holdings' auditor Elliott Davis resigned effective February 27, 2026, after notifying the board on February 25. No disagreements on accounting or auditing matters; prior audits flagged going concern doubts and material weaknesses. Elliott Davis concurs with disclosures. Auditor switch raises control questions.
8-K
Nasdaq delisting notice issued
Bolt Projects Holdings received Nasdaq Panel notice on December 31, 2025, delisting its common stock (BSLK) and warrants (BSLKW) for failing the minimum equity standard under Rule 5550(b)(1), with trading suspended January 5, 2026. No appeal planned; shares shift to OTC Pink Market. Liquidity and volatility risks loom large.
8-K
Raises 2026 guidance sharply
Bolt Projects Holdings announced preliminary 2025 results on December 29, showing ~$4.5M revenue, over 200% YoY growth, and Q4 at >$2.7M with 38% gross margin. It raised 2026 guidance to $11M revenue and $4M gross profit, fueled by cost cuts and new Vegan Silk ingredient. Nasdaq delisting risk lingers.
8-K
Q3 revenue surges 7,300%
Bolt Projects Holdings reported Q3 2025 revenue of $0.4 million, up 7,300% year-over-year, with gross margins hitting 16% from manufacturing efficiencies. Guidance holds at $4.5 million revenue for 2025, $9.0 million for 2026, while raising 2025 gross profit to over $1.0 million implying Q4 margins above 40%. Cash stands at $4.7 million after financings, yet Nasdaq delisting risk lingers.
10-Q
Q3 FY2025 results
Bolt Projects Holdings posted Q3 revenue of $370K, up sharply from $5K y/y yet still tiny against $4.4M operating loss, while YTD revenue hit $1.8M (vs $80K y/y) with gross profit flipping to $119K on manufacturing efficiencies. Operating expenses plunged 78% y/y to $4.4M as stock comp normalized post-merger, but a $3.1M debt extinguishment loss from the Seneca vendor settlement drove net loss to $7.5M ($2.70/share). Cash ticked up to $4.7M on $3.8M equity raises including PIPE and ELOC setup, covering $2.6M YTD operating burn; $12.9M debt matures 2027. Nasdaq granted extension to meet equity rule by year-end. Single customer risk looms large.
IPO
Website
Employees
Sector
Industry
BCPC
Balchem Corporation
157.10-1.61
BGLC
BioNexus Gene Lab Corp
4.12-0.02
BIOE
Bio Essence Corp.
0.05+0.00
BIOF
Blue Biofuels Inc.
0.17-0.01
BKTH
Breakthrough Chemistry Inc.
0.17+0.00
BLGO
BioLargo, Inc.
0.18+0.00
BON
Bon Natural Life Limited
1.79+0.04
KBLB
Kraig Biocraft Laboratories, In
0.09+0.00
LOOP
Loop Industries, Inc.
0.92-0.04
OWPC
One World Products Inc.
0.03+0.01